Advos

Psychedelic Therapy

News Category

Optimi Health Plans Phase 2 Psilocybin Trial for Major Depressive Disorder

Optimi Health Corp. will initiate a Health Canada-authorized Phase 2 clinical trial in 2027 to evaluate psilocybin-assisted therapy for major depressi...

September 10, 2026Read the full article →

Optimi Health Welcomes Australia's Updated TGA Framework for Psychedelic Therapy

Optimi Health Corp. highlights Australia's expanded psychedelic therapy framework, which broadens treatment settings and workforce capacity, potential...

May 29, 2026Read the full article →